secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2023-01-20T23:59:59+00:00
Accession:  0001213900-23-004105
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allarity Therapeutics: three directors resign, board size reduced to 5; annual meeting adjourned to Feb 3
--------------------------------------------------------------------------------

- Directors Duncan Moore and Gail Maderis resigned Jan 19, 2023; Soren G. Jensen resigns effective Feb 4, 2023.
- Board reduced fixed number of authorized directors from 7 to 5 following the resignations.
- 2023 annual meeting adjourned on Jan 19 without business; reconvenes Feb 3, 2023 for additional voting time.
- Resignations stated as for personal reasons, not due to disagreements with company operations or policies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000121390023004105/0001213900-23-004105-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000121390023004105/ea171929-8k_allarity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-004105

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer